India Clinical Diagnostics Market Report 2022 to 2030

India Clinical Diagnostics Market Analysis

$ 3999

India's clinical diagnostic market was valued at $1.25 Bn in 2022 and is estimated to expand at a CAGR of 9% from 2022-30 and will reach $2.5 Bn in 2030. One of the main reasons propelling the growth of this market is an increase in chronic disease and government support. The market is segmented by type, drug, and distribution channel. Some key players in this market are Abbott, BD, bioMérieux SA, Bio-Rad Laboratories, Danaher Corporation, Siemens AG, Hologic, Qiagen NV, Quest Diagnostics, F. Hoffmann-La Roche Ltd, Thyrocare, Suburban Diagnostics, Metropolis Healthcare, SRL Diagnostics, Dr. Lal PathLabs, and others.

ID: IN10INHS003 CATEGORY: Healthcare Services GEOGRAPHY: India AUTHOR: Nandini Shah

Buy Now

India Clinical Diagnostic Market Executive Summary

The India Clinical Diagnostic market was valued at $1.25 Bn in 2022 and is estimated to expand at a CAGR of 9% from 2022-30 and will reach $2.5 Bn in 2030. In India, the clinical diagnostics market is rapidly expanding, with a high need for improved diagnostic technology and solutions. The market has grown dramatically in recent years, owing to rising chronic illness prevalence, a growing elderly population, rising healthcare costs, and government measures to improve early disease identification. With a surge in demand for diagnostic procedures such as RT-PCR and fast antigen tests, the COVID-19 pandemic has also contributed to the expansion of India's clinical diagnostics market. The Indian government has also launched a number of measures to expand testing capacity and access to diagnostic testing.

india clinical diagnostics market analysis

Market Dynamics

Market Growth Drivers

The rising burden of chronic diseases such as diabetes, cardiovascular diseases, and cancer is a major growth driver for the clinical diagnostics market in India. According to the World Health Organization (WHO), non-communicable diseases account for around 60% of all deaths in India. The increasing prevalence of chronic diseases is driving the demand for advanced diagnostic technologies that can provide early and accurate disease detection. The elderly population in India is increasing rapidly, with estimates suggesting that the number of people aged 60 years and above will reach 340 Mn by 2050. The geriatric population is more susceptible to chronic diseases, which is driving the demand for advanced diagnostic solutions. Healthcare expenditure in India has been rising steadily, driven by an increase in disposable income, growing awareness about health, and government initiatives to improve healthcare infrastructure.

According to the World Band in 2019, the total healthcare expenditure in India was around 3.01% of the GDP. The Indian government has launched several initiatives to promote early disease detection and improve access to diagnostic testing. The National Health Policy 2017 aims to increase public health expenditure to 2.5% of GDP and provide universal access to quality healthcare services. The government has also launched programs such as the Ayushman Bharat Yojana, which aims to provide health insurance coverage to around 100 Mn families. The clinical diagnostics market in India is witnessing significant technological advancements, with the introduction of new diagnostic technologies such as point-of-care testing, molecular diagnostics, and next-generation sequencing. These technologies are providing faster and more accurate diagnostic results, which is driving the demand for advanced diagnostic solutions.

Market Restraints

The clinical diagnostics market in India is facing a shortage of skilled professionals, including laboratory technicians and pathologists. According to a report by the Indian Council of Medical Research (ICMR), there is a shortage of around 70,000 laboratory professionals in India. There is a low level of awareness among the general population regarding the importance of diagnostic testing, which is limiting the growth of the clinical diagnostics market in India. According to a survey conducted by Abbott, only 10% of Indians believe that diagnostic testing is important for maintaining good health.

Advanced diagnostic technologies such as molecular diagnostics and next-generation sequencing are expensive and require significant investment in infrastructure and equipment. This is a major barrier to entry for smaller players in the market and limits the adoption of advanced diagnostic technologies. There is a lack of standardization in diagnostic testing practices in India, which can lead to inconsistent results and inaccurate diagnoses. This is particularly true in the case of point-of-care testing, where there is a lack of standardization in device performance and accuracy. The clinical diagnostics market in India is subject to a complex regulatory environment, which can create barriers to entry for new players in the market. The regulatory environment in India is also subject to frequent changes, which can make it difficult for companies to navigate the regulatory landscape.

Competitive Landscape

Key Players

Abbott
Bio-Rad Laboratories
Danaher Corporation
Siemens
Qiagen NV
Quest Diagnostics
F. Hoffmann-La Roche
Thyrocare
Suburban Diagnostics
Metropolis Healthcare
SRL Diagnostics
Dr. Lal PathLabs

Healthcare Policies and Regulatory Landscape

The healthcare policy and regulatory market in India is complex and dynamic. The regulatory framework for healthcare in India is governed by several laws and regulations that are overseen by various government agencies. The Clinical Establishments (Registration and Regulation) Act, regulates the registration and regulation of clinical establishments in India. It sets standards for the quality of care provided by clinical establishments and establishes the regulatory framework for clinical trials in India. The National Health Policy, the policy outlines the government's vision for healthcare in India and sets out a roadmap for achieving universal health coverage. It also sets out the government's priorities for healthcare reform, including the development of a comprehensive healthcare system that is accessible to all.

Reimbursement Scenario

The reimbursement scenario in India's healthcare system is complex and varies depending on the type of healthcare service and the source of funding. Unlike many developed countries, India does not have a universal health insurance system, and a large portion of the population pays for healthcare services out of pocket. However, the government provides some reimbursement for certain healthcare services through various programs. The government operates several health insurance programs, including the Ayushman Bharat scheme, which provides coverage for up to 500 Mn people living below the poverty line. Under this scheme, eligible beneficiaries are provided with a health insurance card that can be used to access medical treatment at designated hospitals. The scheme covers the cost of treatment up to a certain amount, and the government reimburses the hospital directly for the cost of the treatment.

In addition to government-sponsored insurance programs, there are also several private health insurance providers in India that offer coverage for healthcare services. The coverage provided by private health insurance providers varies depending on the type of plan and the premium paid by the insured. For certain healthcare services, such as dialysis and cancer treatment, the government has introduced reimbursement schemes to provide financial assistance to patients. For example, the Rashtriya Arogya Nidhi scheme provides financial assistance to patients with life-threatening diseases who are below the poverty line and cannot afford treatment.

1. Executive Summary
1.1 Service Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Healthcare Services Market in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Services
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

India Clinical Diagnostics Market Segmentation

By Test

Lab Test
Imaging Test
Other Tests

By Product

Instruments
Reagents
Other Products

By End User (Revenue, USD Bn)

Hospital Laboratory
Diagnostic Laboratory
Point-of-care Testing
Other End Users

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.